Results 171 to 180 of about 13,742 (189)

Mifepristone: Antineoplastic Studies

Clinical Obstetrics and Gynecology, 1996
Emerging research suggests that mifepristone may have significant clinical applications in the treatment of certain neoplastic disorders. For example in vitro studies have shown that RU-486 can inhibit or stimulate--depending on the cell line and the hormonal milieu of the culture medium--the growth of breast cancer cells. In hormone-sensitive breast
O, Sartor, W D, Figg
openaire   +2 more sources

Mifepristone

Reactions Weekly, 2016
  +7 more sources

Mifepristone

Reactions Weekly, 2007
S.J. Enna, David B. Bylund
  +5 more sources

Mifepristone

Reactions Weekly, 2012
openaire   +2 more sources

RETIRED: Mifepristone

Journal of Obstetrics and Gynaecology Canada, 2003
openaire   +2 more sources

Mifepristone

Reactions Weekly, 2022
openaire   +1 more source

Mifepristone at home

BMJ, 2022
Sharon, Cameron, John, Reynolds-Wright
openaire   +2 more sources

Mifepristone

Reactions Weekly, 2019
openaire   +1 more source

Mifepristone

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2010
Ho, PC, Tang, FOS
openaire   +3 more sources

Mifepristone

The Lancet, 1993
openaire   +1 more source